Contribution of somal Lewy bodies to neuronal death

Margaret M. Tompkins, William D Hill

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Neuronal degeneration occurs in the substantia nigra pars compacta (SNpc) of patients with Parkinson's disease and other Lewy body-associated disorders. Lewy bodies (LBs) are abnormal inclusions found in the SNpc and other neurons of these patients. It is not known what role LBs play in the disease process; they may be harmful to the neuron or simply an epiphenomenon of the disease process. We have previously shown that some of the neuronal death occurring in the SNpc of Lewy body-associated disorders resembles apoptosis. The present study was undertaken to determine whether apoptotic- like changes were more common in SNpc neurons with somal LBs compared to those without somal LBs. Substantia nigra from cases of Lewy body-associated disorders were labeled to colocalize apoptotic-like changes and LBs using in situ end-labeling and an anti-ubiquitin antibody. Three cases demonstrated that SNpc neurons with LBs in the perikarya had the same proportion of apoptotic-like changes as SNpc neurons without somal LBs. One case had no LB- containing SNpc neurons undergoing apoptotic-like cell death. The majority of SNpc neurons undergoing apoptotic-like cell death did not appear to contain somal LBs and thus may be dying before LB formation can occur. These results support the theory that the presence of a somal LB does not predispose a neuron to undergo apoptotic-like cell death.

Original languageEnglish (US)
Pages (from-to)24-29
Number of pages6
JournalBrain Research
Volume775
Issue number1-2
DOIs
StatePublished - Nov 14 1997

Fingerprint

Lewy Bodies
Neurons
Cell Death
Pars Compacta
Substantia Nigra
Ubiquitin
Parkinson Disease
Anti-Idiotypic Antibodies

Keywords

  • Apoptosis
  • Diffuse Lewy body disease
  • In situ end labeling
  • Lewy body
  • Neurodegeneration
  • Parkinson's disease
  • Substantia nigra

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Contribution of somal Lewy bodies to neuronal death. / Tompkins, Margaret M.; Hill, William D.

In: Brain Research, Vol. 775, No. 1-2, 14.11.1997, p. 24-29.

Research output: Contribution to journalArticle

Tompkins, Margaret M. ; Hill, William D. / Contribution of somal Lewy bodies to neuronal death. In: Brain Research. 1997 ; Vol. 775, No. 1-2. pp. 24-29.
@article{52eaa3e4467c4f2aa248a7b17a04c767,
title = "Contribution of somal Lewy bodies to neuronal death",
abstract = "Neuronal degeneration occurs in the substantia nigra pars compacta (SNpc) of patients with Parkinson's disease and other Lewy body-associated disorders. Lewy bodies (LBs) are abnormal inclusions found in the SNpc and other neurons of these patients. It is not known what role LBs play in the disease process; they may be harmful to the neuron or simply an epiphenomenon of the disease process. We have previously shown that some of the neuronal death occurring in the SNpc of Lewy body-associated disorders resembles apoptosis. The present study was undertaken to determine whether apoptotic- like changes were more common in SNpc neurons with somal LBs compared to those without somal LBs. Substantia nigra from cases of Lewy body-associated disorders were labeled to colocalize apoptotic-like changes and LBs using in situ end-labeling and an anti-ubiquitin antibody. Three cases demonstrated that SNpc neurons with LBs in the perikarya had the same proportion of apoptotic-like changes as SNpc neurons without somal LBs. One case had no LB- containing SNpc neurons undergoing apoptotic-like cell death. The majority of SNpc neurons undergoing apoptotic-like cell death did not appear to contain somal LBs and thus may be dying before LB formation can occur. These results support the theory that the presence of a somal LB does not predispose a neuron to undergo apoptotic-like cell death.",
keywords = "Apoptosis, Diffuse Lewy body disease, In situ end labeling, Lewy body, Neurodegeneration, Parkinson's disease, Substantia nigra",
author = "Tompkins, {Margaret M.} and Hill, {William D}",
year = "1997",
month = "11",
day = "14",
doi = "10.1016/S0006-8993(97)00874-3",
language = "English (US)",
volume = "775",
pages = "24--29",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Contribution of somal Lewy bodies to neuronal death

AU - Tompkins, Margaret M.

AU - Hill, William D

PY - 1997/11/14

Y1 - 1997/11/14

N2 - Neuronal degeneration occurs in the substantia nigra pars compacta (SNpc) of patients with Parkinson's disease and other Lewy body-associated disorders. Lewy bodies (LBs) are abnormal inclusions found in the SNpc and other neurons of these patients. It is not known what role LBs play in the disease process; they may be harmful to the neuron or simply an epiphenomenon of the disease process. We have previously shown that some of the neuronal death occurring in the SNpc of Lewy body-associated disorders resembles apoptosis. The present study was undertaken to determine whether apoptotic- like changes were more common in SNpc neurons with somal LBs compared to those without somal LBs. Substantia nigra from cases of Lewy body-associated disorders were labeled to colocalize apoptotic-like changes and LBs using in situ end-labeling and an anti-ubiquitin antibody. Three cases demonstrated that SNpc neurons with LBs in the perikarya had the same proportion of apoptotic-like changes as SNpc neurons without somal LBs. One case had no LB- containing SNpc neurons undergoing apoptotic-like cell death. The majority of SNpc neurons undergoing apoptotic-like cell death did not appear to contain somal LBs and thus may be dying before LB formation can occur. These results support the theory that the presence of a somal LB does not predispose a neuron to undergo apoptotic-like cell death.

AB - Neuronal degeneration occurs in the substantia nigra pars compacta (SNpc) of patients with Parkinson's disease and other Lewy body-associated disorders. Lewy bodies (LBs) are abnormal inclusions found in the SNpc and other neurons of these patients. It is not known what role LBs play in the disease process; they may be harmful to the neuron or simply an epiphenomenon of the disease process. We have previously shown that some of the neuronal death occurring in the SNpc of Lewy body-associated disorders resembles apoptosis. The present study was undertaken to determine whether apoptotic- like changes were more common in SNpc neurons with somal LBs compared to those without somal LBs. Substantia nigra from cases of Lewy body-associated disorders were labeled to colocalize apoptotic-like changes and LBs using in situ end-labeling and an anti-ubiquitin antibody. Three cases demonstrated that SNpc neurons with LBs in the perikarya had the same proportion of apoptotic-like changes as SNpc neurons without somal LBs. One case had no LB- containing SNpc neurons undergoing apoptotic-like cell death. The majority of SNpc neurons undergoing apoptotic-like cell death did not appear to contain somal LBs and thus may be dying before LB formation can occur. These results support the theory that the presence of a somal LB does not predispose a neuron to undergo apoptotic-like cell death.

KW - Apoptosis

KW - Diffuse Lewy body disease

KW - In situ end labeling

KW - Lewy body

KW - Neurodegeneration

KW - Parkinson's disease

KW - Substantia nigra

UR - http://www.scopus.com/inward/record.url?scp=0031474418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031474418&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(97)00874-3

DO - 10.1016/S0006-8993(97)00874-3

M3 - Article

C2 - 9439824

AN - SCOPUS:0031474418

VL - 775

SP - 24

EP - 29

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -